CLINICAL_TRIALS
trial_result
· 2018-03-29
Clinical Trial Update: Effect of Methyldopa on MHC Class II Antigen Presentation in Type 1 Diabetes [NA]
Summary
A completed clinical trial evaluating the effect of methyldopa on MHC II antigen presentation in type 1 diabetes; results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Colorado, Denver | Conditions: Diabetes Mellitus, Type 1 | NA | Status: COMPLETED | Results posted: 2018-03-29